Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Source: US Top News and Analysis
Related Posts
Super Micro stock jumps 19% on guidance beat as revenue more than doubles
Super Micro pointed to progress in U.S. manufacturing in issuing a stronger-than-expected quarterly forecast. Source:…
China consumer, wholesale inflation tops estimates in April as Iran war drives energy costs higher
China has cushioned the worst of the energy shock through its strategic oil stockpiles and…
U.S. payrolls increased 115,000 in April, more than expected; unemployment at 4.3%
Nonfarm payrolls were expected to increase by 55,000 in April, according to the Dow Jones…